Hebatallah Hassan
Associate professor of cancer biology
(email)
Publications
Bio
Classes
Calendar
http://www.ncbi.nlm.nih.gov/pubmed/23206733
http://www.ncbi.nlm.nih.gov/pubmed/23289672
http://www.ncbi.nlm.nih.gov/pubmed/24392029
http://www.ncbi.nlm.nih.gov/pubmed/24462576
http://www.ncbi.nlm.nih.gov/pubmed/25168226
https://pubmed.ncbi.nlm.nih.gov/36980680/
https://www.ncbi.nlm.nih.gov/pubmed/27482469
Motta, J. M., H. Hassan, and S. A. A. Ibrahim,
"
Revisiting the Syndecans: Master Signaling Regulators with Prognostic and Targetable Therapeutic Values in Breast Carcinoma
",
Cancers (Basel)
, vol. 15, issue 6, pp. 1794, 2023.
Ibrahim, S. M., A. I. Othman, H. Hassan, S. A. A. Ibrahim, and M. Götte,
"
The Regulatory Role of Syndecan-1 on Human MiR-222-3p Expression in Breast Cancer Cell Lines
",
Egyptian Journal of Histology
, vol. 42, issue 3, pp. 534-539, 2019.
Mohamed, H. T., R. Gadalla, N. El-Husseiny, H. Hassan, Z. Wang, S. A. Ibrahim, M. El-Shinawi, D. H. Sherr, and M. M. Mohamed,
"
Inflammatory breast cancer: Activation of the aryl hydrocarbon receptor and its target CYP1B1 correlates closely with Wnt5a/b-$\beta$-catenin signalling, the stem cell phenotype and disease progression
",
Journal of Advanced Research
: Elsevier, 2018.
Abstract
n/a
Ibrahim, S. A. A., R. Gadalla, E. A. El-Ghonaimy, O. Samir, H. T. Mohamed, H. Hassan, B. Greve, M. El-Shinawi, M. M. Mohamed, and M. Götte,
"
Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways
",
Molecular cancer
, vol. 16, no. 1: BioMed Central, pp. 57, 2017.
Abstract
n/a
SA, I., E. - G. EA, H. H, Mahana N, M. MA, E. - M. T, E. - S. M, and M. MM,
"
1. Hormonal-receptor positive breast cancer: IL-6 augments invasion and lymph node metastasis via stimulating cathepsin B expression.
",
J Adv Res
, vol. 7, issue 5, pp. 661-70., 2016.
hormonal-receptor_positive_breast_.pdf
SA, I., H. H, and G. M.,
"
MicroRNA-dependent targeting of the extracellular matrix as a mechanism of regulating cell behavior.
",
Biochim Biophys Acta
, vol. 1840, issue 8, pp. 2609-20, 2014.
SA, I., H. H, and G. M,
"
MicroRNA regulation of proteoglycan function in cancer.
",
FEBS J.
, vol. 281, issue 22, pp. 5009-22, 2014.
C, S., K. N, G. B, H. H,, Jouini R, and et al,
"
Targeting of syndecan-1 by micro-ribonucleic acid miR-10b modulates invasiveness of endometriotic cells via dysregulation of the proteolytic milieu and interleukin-6 secretion.
",
Fertil Steril
, vol. 1;99(3):871-881, 2013.
H, H., G. B, P. MS, K. L, I. SA, and G. M,
"
Syndecan-1 modulates β-integrin-dependent and interleukin-6-dependent functions in breast cancer cell adhesion, migration, and resistance to irradiation.
",
FEBS J
, vol. 280(10):2216-27, 2013.
SA, I., H. H, V. L,, Jouini R, and et al,
"
Syndecan-1 (CD138) Modulates Triple-Negative Breast Cancer Stem Cell Properties via Regulation of LRP-6 and IL-6-Mediated STAT3 Signaling.
",
PLoS One
, vol. 31;8(12):e85737., 2013.
Upcoming events